Evelyn Partners Investment Management LLP Takeda Pharmaceutical CO LTD Transaction History
Evelyn Partners Investment Management LLP
- $3.52 Trillion
- Q3 2025
A detailed history of Evelyn Partners Investment Management LLP transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Evelyn Partners Investment Management LLP holds 167 shares of TAK stock, worth $2,386. This represents 0.0% of its overall portfolio holdings.
Number of Shares
167
Previous 2,515
93.36%
Holding current value
$2,386
Previous $2.58 Million
5.23%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TAK
# of Institutions
371Shares Held
77.2MCall Options Held
895KPut Options Held
143K-
Capital Research Global Investors Los Angeles, CA13.4MShares$192 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.69MShares$110 Million0.01% of portfolio
-
Ubs Group Ag5.89MShares$84.2 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.95MShares$70.8 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.93MShares$56.2 Million0.48% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $44.4B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...